N-(4-hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: Retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153

Journal of Cellular Physiology

Volumn 209, Issue 3, 2006, Pages 854-865

  Samuel, William ^a   Kutty, R Krishnan ^a   Nagineni, Sahrudaya ^a   Vijayasarathy, Camasamudram ^b   Chandraratna, Roshantha A S ^c   Wiggert, Barbara ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^c ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; AGN 194301; AGN 194310; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CASPASE 2; CASPASE 3; DICHLOROFLUORESCEIN; DNA; FENRETINIDE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEME OXYGENASE 1; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; RECEPTOR BLOCKING AGENT; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER PREVENTION; CELL CULTURE; CELL DEATH; CELL STRAIN; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NUCLEOSOME; OXIDATION; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME;

ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CASPASE 2; CASPASE 3; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EPITHELIAL CELLS; FENRETINIDE; HEME OXYGENASE-1; HUMANS; PIGMENT EPITHELIUM OF EYE; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; RECEPTORS, RETINOIC ACID; RNA INTERFERENCE; TRANSCRIPTION FACTOR CHOP;

EID: 33750495809     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20774     Document Type: Article

References (63)

1. Abraham NG, Kappas A. 2005. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 39:1-25.
2. Bok D. 1993. The retinal pigment epithelium: A versatile partner in vision. J Cell Sci Suppl 17:189-195.
3. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. 1995. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci 92:7162-7166.
4. Camerini T, Mariani L, De Palo G, Marubini E, Di Mauro MG, Decensi A, Costa A, Veronesi U. 2001. Safety of the synthetic retinoid fenretinide: Long-term results from a controlled clinical trial for the prevention of contralateral breast cancer. J Clin Oncol 19:1664-1670.
5. Chambon P. 1994. The retinoid signaling pathway: Molecular and genetic analyses. Semin Cell Biol 5:115-125.
6. Chen S, Samuel W, Fariss RN, Duncan T, Kutty RK, Wiggert B. 2003. Differentiation of human retinal pigment epithelial cells into neuronal phenotype by N-(4-hydroxyphenyl)retinamide. J Neurochem 84:972-981.
7. Clifford JL, Menter DG, Wang M, Lotan R, Lippman SM. 1999. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res 59:14-18.
8. De Palo G, Veronesi U, Camerini T, Formelli F, Mascotti G, Boni C, Fosser V, Del Vecchio M, Campa T, Costa A. 1995. Can fenretinide protect women against ovarian cancer? J Natl Cancer Inst 87:146-147.
9. Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F, Formelli F, Menard S, Costa A, Veronesi U. 1993. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 53:6036-6041.
10. Delia D, Aiello A, Meroni L, Nicolini M, Reed JC, Pierotti MA. 1997. Role of antioxidants and intracellular free radicals in retinamide-induced cell death. Carcinogenesis 18:943-948.
11. Di Vinci A, Geido E, Infusini E, Giaretti W. 1994. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Int J Cancer 59:422-426.
12. Dmitrovsky E. 1997. N-(4-hydroxyphenyl)retinamide activation of a distinct pathway signaling apoptosis. J Natl Cancer Inst 89:1179-1181.
13. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. 1996. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62:155-169.
14. Fanjul AN, Delia D, Pierotti MA, Rideout D, Yu JQ, Pfahl M, Qiu J. 1996. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J Biol Chem 271:22441-22446.
15. Formelli F, Clerici M, Campa T, Di Mauro MG, Magni A, Mascotti G, Moglia D, De Palo G, Costa A, Veronesi U. 1993. Five-year administration of fenretinide: Pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol 11:2036-2042.
16. Hartsfield CL, Alam J, Choi AM. 1998. Transcriptional regulation of the heme oxygenase 1 gene by pyrrolidine dithiocarbamate. FASEB J 12:1675-1682.
17. Johnson AT, Wang L, Standeven AM, Escobar M, Chandraratna RA. 1999. Synthesis and biological activity of high-affinity retinoic acid receptor antagonists. Bioorg Med Chem 7:1321-1338.
18. Jurisic V, Spuzic I, Konjevic G. 1999. A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cells, determined by LDH release assay. Cancer Lett 138:67-72.
19. Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M. 1995. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J Natl Cancer Inst 87:1674-1680.
20. Kazmi SM, Plante RK, Visconti V, Lau CY. 1996. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res 56:1056-1062.
21. Kim DG, You KR, Liu MJ, Choi YK, Won YS. 2002. GADD153-mediated anticancer effects of N-(4-hydroxyphenyl)retinamide on human hepatoma cells. J Biol Chem 277:38930-38938.
22. Kutty RK, Kutty G, Nagineni CN, Hooks JJ, Chader GJ, Wiggert B. 1994a. RT-PCR assay for heme oxygenase-1 and heme oxygenase-2: A sensitive method to estimate cellular oxidative damage. Ann N Y Acad Sci 738:427-430.
23. Kutty RK, Nagineni CN, Kutty G, Hooks JJ, Chader GJ, Wiggert B. 1994b. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol 159:371-378.
24. Kutty RK, Kutty G, Wiggert B, Chader GJ, Darrow RM, Organisciak DT. 1995. Induction of heme oxygenase 1 in the retina by intense visible light: Suppression by the antioxidant dimethylthiourea. Proc Natl Acad Sci 92:1177-1181.
25. Lai WL, Wong NS. 2005. ROS mediates 4HPR-induced posttranscriptional expression of the Gadd153 gene. Free Radic Biol Med 38:1585-1593.
26. Le Bras M, Clement MV, Pervaiz S, Brenner C. 2005. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 20:205-219.
27. Lengwehasatit I, Dickson AJ. 2002. Analysis of the role of GADD153 in the control of apoptosis in NSO myeloma cells. Biotechnol Bioeng 80:719-730.
28. Lotan R. 1995. Retinoids and apoptosis: Implications for cancer chemoprevention and therapy. J Natl Cancer Inst 87:1655-1657.
29. Lovat PE, Ranalli M, Annichiarrico-Petruzzelli M, Bernassola F, Piacentini M, Malcolm AJ, Pearson AD, Melino G, Redfern CP. 2000. Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. Exp Cell Res 260:50-60.
30. Lovat PE, Oliverio S, Ranalli M, Corazzari M, Rodolfo C, Bernassola F, Aughton K, Maccarrone M, Hewson QD, Pearson AD, Melino G, Piacentini M, Redfern CP. 2002. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res 62:5158-5167.
31. Lowenstein A, Bressler NM, Bressler SB. 1998. Epidemiology of age-related retinal pigment epithelial disease. In: Marmor MF, Wolfensberger TJ, editors. The retinal pigment epithelium. New York: Oxford University Press, pp 716-725.
32. Maines MD. 2000. The heme oxygenase system and its functions in the brain. Cell Mol Biol 46:573-585.
33. Majno G, Joris I. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15.
34. Malone W, Perloff M, Crowell J, Sigman C, Higley H. 2003. Fenretinide: A prototype cancer prevention drug. Expert Opin Investig Drugs 12:1829-1842.
35. Mangelsdorf DJ, Umesono K, Evans RM. 1994. The retinoid receptors. In: Sporn MB, Roberts AB Goodman DS, editors. The retinoids: Biology, Chemistry, and Medicine. New York: Raven Press. 319 p.
36. McCaffery P, Mey J, Drager UC. 1996. Light-mediated retinoic acid production. Proc Natl Acad Sci 93:12570-12574.
37. Nicholson DW. 1999. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6:1028-1042.
38. Oridate N, Lotan D, Mitchell MF, Hong WK, Lotan R. 1995. Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: Implications for chemoprevention. J Cell Biochem 23:80-86.
39. Oridate N, Lotan D, Xu XC, Hong WK, Lotan R. 1996. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2:855-863.
40. Oridate N, Suzuki S, Higuchi M, Mitchell MF, Hong WK, Lotan R. 1997. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst 89:1191-1198.
41. Padanilam BJ. 2003. Cell death induced by acute renal injury: A perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284: F608-F627.
42. Pergolizzi R, Appierto V, Crosti M, Cavadini E, Cleris L, Guffanti A, Formelli F. 1999. Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells. Int J Cancer 81:829-834.
43. Phelan JK, Bok D. 2000. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis 6:116-124.
44. Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG. 1995. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: Apoptosis versus differentiation. Cancer Res 55:853-861.
45. Radu RA, Han Y, Bui TV, Nusinowitz S, Bok D, Lichter J, Widder K, Travis GH, Mata NL. 2005. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: A potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci 46:4393-4401.
46. Sabichi AL, Hendricks DT, Bober MA, Birrer MJ. 1998. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. J Natl Cancer Inst 90:597-605.
47. Samuel W, Kutty RK, Nagineni S, Gordon JS, Prouty SM, Chandraratna RA, Wiggert B. 2001. Regulation of stearoyl coenzyme A desaturase expression in human retinal pigment epithelial cells by retinoic acid. J Biol Chem 276:28744-28750.
48. Sheikh MS, Shao ZM, Li XS, Ordonez JV, Conley BA, Wu S, Dawson MI, Han QX, Chao WR, Quick T. 1995. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis 16:2477-2486.
49. Standeven AM, Johnson AT, Escobar M, Chandraratna RA. 1996. Specific antagonist of retinoid toxicity in mice. Toxicol Appl Pharmacol 138:169-175.
50. Stocker R, McDonagh AF, Glazer AN, Ames BN. 1990. Antioxidant activities of bile pigments: Biliverdin and bilirubin. Methods Enzymol 186:301-309.
51. Strauss O. 2005. The retinal pigment epithelium in visual function. Physiol Rev 85:845-881.
52. Stuhlmeier KM. 2000. Activation and regulation of Hsp32 and Hsp70. Eur J Biochem 267:1161-1167.
53. Sun SY, Li W, Yue P, Lippman SM, Hong WK, Lotan R. 1999. Mediation of N-(4-hydoxyphenyl)-retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 59:2493-2498.
54. Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R. 2000. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res 6:1563-1573.
55. Sun SY, Yue P, Kelloff GJ, Steele VE, Lippman SM, Hong WK, Lotan R. 2001. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)- retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells. Cancer Epidemiol Biomarkers Prev 10:595-601.
56. Supino R, Crosti M, Clerici M, Warlters A, Cleris L, Zunino F, Formelli F. 1996. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int J Cancer 65:491-497.
57. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M, Sager R. 1994. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 5:133-141.
58. Terui Y, Furukawa Y, Kikuchi J, Saito M. 1995. Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest. J Cell Physiol 164:74-84.
59. Thornberry NA, Lazebnik Y. 1998. Caspases: Enemies within. Science 281:1312-1316.
60. Tsuchihashi S, Tamaki T, Tanaka M, Kawamura A, Kaizu T, Ikeda A, Kakita A. 2003. Pyrrolidine dithiocarbamate provides protection against hypothermie preservation and transplantation injury in the rat liver: The role of heme oxygenase-1. Surgery 133:556-567.
61. Ulukaya E, Wood EJ. 1999. Fenretinide and its relation to cancer. Cancer Treat Rev 25:229-235.
62. Xia Y, Wong NS, Fong WF, Tideman H. 2002. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR). Int J Cancer 102:7-14.
63. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D. 1998. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982-995.